14P Deep learning-based quantification of immune infiltrate for predicting response to pembrolizumab from pre-treatment biopsies of metastatic non-small cell lung cancer: A study on the PEMBRO-RT phase II trial. (December 2022) - Spronck, J.; Eekelen, L.V.; Tessier, L.; Bogaerts, J.; van der Woude, L.; van den Heuvel, M.; Theelen, W.; Ciompi, F.